These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 18199714
21. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor. Sutter AP, Maaser K, Höpfner M, Huether A, Schuppan D, Scherübl H. J Hepatol; 2005 Nov; 43(5):808-16. PubMed ID: 16083991 [Abstract] [Full Text] [Related]
22. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins. Konturek PC, Burnat G, Hahn EG. J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():141-8. PubMed ID: 17901590 [Abstract] [Full Text] [Related]
27. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK. Koyuturk M, Ersoz M, Altiok N. Cancer Lett; 2007 Jun 08; 250(2):220-8. PubMed ID: 17125918 [Abstract] [Full Text] [Related]
34. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor. Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H, Suzuki K. Biochem Biophys Res Commun; 2008 Jul 25; 372(2):356-61. PubMed ID: 18489904 [Abstract] [Full Text] [Related]
35. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. Kah J, Wüstenberg A, Keller AD, Sirma H, Montalbano R, Ocker M, Volz T, Dandri M, Tiegs G, Sass G. Oncol Rep; 2012 Sep 25; 28(3):1077-83. PubMed ID: 22710979 [Abstract] [Full Text] [Related]
36. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS. J Pharmacol Exp Ther; 2008 Jun 25; 325(3):841-9. PubMed ID: 18337475 [Abstract] [Full Text] [Related]
38. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis. Horiguchi A, Sumitomo M, Asakuma J, Asano T, Asano T, Hayakawa M. Clin Cancer Res; 2004 Dec 15; 10(24):8648-55. PubMed ID: 15623649 [Abstract] [Full Text] [Related]
39. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations. Murtola TJ, Pennanen P, Syvälä H, Bläuer M, Ylikomi T, Tammela TL. Prostate; 2009 Jun 15; 69(9):1017-23. PubMed ID: 19301305 [Abstract] [Full Text] [Related]
40. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. Moriceau G, Roelofs AJ, Brion R, Redini F, Ebetion FH, Rogers MJ, Heymann D. Cancer; 2012 Feb 01; 118(3):750-60. PubMed ID: 21751201 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]